These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Alvarez-Sabín J; Román GC Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117 [TBL] [Abstract][Full Text] [Related]
4. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors. Erkinjuntti T; Román G; Gauthier S Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282 [TBL] [Abstract][Full Text] [Related]
5. Targeting Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) for the Intervention of Vascular Cognitive Impairment and Dementia. Yang T; Zhang F Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):97-116. PubMed ID: 33054394 [TBL] [Abstract][Full Text] [Related]
6. Towards Combinatorial Approaches for Preserving Cognitive Fitness in Aging. Brem AK; Sensi SL Trends Neurosci; 2018 Dec; 41(12):885-897. PubMed ID: 30343822 [TBL] [Abstract][Full Text] [Related]
7. [Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness]. Levada OA; Traïlin AV Lik Sprava; 2012; (3-4):53-9. PubMed ID: 23356138 [TBL] [Abstract][Full Text] [Related]
8. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl). Maelicke A Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacological treatment of vascular cognitive impairment]. Bidzan L Przegl Lek; 2006; 63(3):131-3. PubMed ID: 16969897 [TBL] [Abstract][Full Text] [Related]
10. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia. Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937 [TBL] [Abstract][Full Text] [Related]
11. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors. Erkinjuntti T; Román G; Gauthier S J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522 [TBL] [Abstract][Full Text] [Related]
12. Dementia with cerebrovascular disease: the benefits of early treatment. Schindler RJ Eur J Neurol; 2005 Oct; 12 Suppl 3():17-21. PubMed ID: 16144533 [TBL] [Abstract][Full Text] [Related]
15. Bee Venom Ameliorates Cognitive Dysfunction Caused by Neuroinflammation in an Animal Model of Vascular Dementia. Cai M; Lee JH; Yang EJ Mol Neurobiol; 2017 Oct; 54(8):5952-5960. PubMed ID: 27686075 [TBL] [Abstract][Full Text] [Related]